Papers
3
Total Citations
25
H-Index
3
About
Dr. Pengjun Xu is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for benign prostatic hyperplasia (BPH) and renal tumors. His major contributions lie in the comparative effectiveness of robotic-assisted procedures, particularly in prostate and kidney surgery. In a pivotal 2023 study (11 citations), Dr. Xu systematically compared robotic-assisted simple prostatectomy with laser enucleation for large BPH, providing crucial evidence for surgical decision-making. He further advanced the field through a 2024 meta-analysis (8 citations) evaluating transperitoneal versus retroperitoneal robotic partial nephrectomy for posterior-lateral renal tumors, offering guidance on optimal surgical approaches. Dr. Xu’s innovative work also includes investigating near-infrared fluorescence imaging with indocyanine green for selective arterial clamping during robotic partial nephrectomy (6 citations), demonstrating how real-time vascular visualization can improve perioperative outcomes and preserve renal function. His research consistently employs rigorous meta-analytic methodologies to synthesize evidence, making him a valuable resource for surgeons seeking data-driven approaches to complex urologic procedures. With over 25 total citations across his most influential works, Dr. Xu continues to shape the landscape of robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3